Market Overview:
The global oxycodone market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic pain, increasing use of opioids for pain management, and growing demand for long-acting oxycodone formulations. However, the high abuse potential of oxycodone and stringent regulatory framework are some of the major factors that are restraining the growth of this market. On the basis of type, long-acting oxycodone formulations accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to their longer duration of action as compared to short-acting formulations and their growing popularity among patients suffering from chronic pain conditions. By application, hospital pharmacies held a larger share in 2017 and is expected to continue its dominance during the forecast period owing to rising number of surgeries performed across hospitals globally coupled with increasing adoption rates for long-acting oxycodone formulations by surgeons for postoperative analgesia therapy.
Product Definition:
Oxycodone is a prescription medication used to treat moderate to severe pain. It can be taken as a pill, capsule, or liquid.
Long Acting Oxycodone:
Long-acting opioids are a class of opioid drugs that bind to the opiate receptor in the brain more strongly than short-acting ones, which means they produce effects such as drowsiness and relaxation for a longer period. The most commonly used long-acting opioids are hydrocodone (Vicodin) and oxycodone (OxyContin).
Short Acting Oxycodone:
Short acting oxycodone is a type of opioid drug, which is used to treat pain. It works by binding to the receptors in the brain and spinal cord that are associated with pain. Short-acting opioids have a much lower risk of causing addiction than long-acting ones do; as a result, they are often preferred for treating acute pain.
Application Insights:
Hospital pharmacies accounted for the largest revenue share of around 59.0% in 2017 owing to high usage of oxycodone in hospital based treatment for chronic pain. The growing number of hospital based procedures is expected to contribute towards market growth over the forecast period. Furthermore, increasing government expenditure on the development of healthcare infrastructure and rising prevalence of chronic pain are further anticipated to drive industry expansion over the coming years.
Retail pharmacies accounted for a significant revenue share in 2017 owing to rapid penetration and easy availability at comparatively lower prices as compared with other countries or regions where OxyContin is available under similar circumstances such as quality standards, manufacturing cost etcetera which are followed by retail pharmacy owners globally who import drugs from foreign markets where these drugs have been commercially successful due to different sets of rules and regulations that may or may not be favorable towards its consumption which can be attributed towards market growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing cases of chronic pain and other disorders coupled with rising opioid dependence in the U.S., Canada, and Mexico.
Asia Pacific is expected to be one of the fastest-growing regions during the same period owing to rapid economic development coupled with improving healthcare infrastructure especially in China and India which are some of largest markets globally for these drugs OxyContin (oxycodone).
Growth Factors:
- Increasing prevalence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages. Oxycodone is an effective treatment for moderate to severe pain and has a favorable safety profile, making it a preferred choice for many patients.
- Availability of generic versions: Generic versions of oxycodone are available in many countries, which helps make this drug more affordable for patients.
- Growing use in cancer pain management: Cancer remains a leading cause of death worldwide and one of the most common causes of chronic pain. Oxycodone is increasingly being used to manage cancer-related pain due to its efficacy and safety profile.
- Expanding indications for use: Oxycodone is approved for use in a wide range of conditions, including acute and chronicpain, postoperative pain, labor pains, and headaches caused by migraine or cluster headaches . This broad indication coverage makes it an attractive option for physicians treating patients with various typesofpain .
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxycodone Market Research Report
By Type
Long Acting Oxycodone, Short Acting Oxycodone
By Application
Hospital Pharmacies, Retail Pharmacies, Others
By Companies
Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt, Mylan, Sun Pharmaceutical (Chattem Chemicals), Impax Laboratories, Indivior
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Oxycodone Market Report Segments:
The global Oxycodone market is segmented on the basis of:
Types
Long Acting Oxycodone, Short Acting Oxycodone
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Sanofi
- Pfizer
- Purdue Pharma
- Endo International
- Teva Pharmaceuticals
- Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
- Mallinckrodt
- Mylan
- Sun Pharmaceutical (Chattem Chemicals)
- Impax Laboratories
- Indivior
Highlights of The Oxycodone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Long Acting Oxycodone
- Short Acting Oxycodone
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxycodone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxycodone is a narcotic pain reliever that is used to relieve moderate to severe pain. It is also used as an opioid medication for treating addiction to other opioids, such as heroin and morphine. Oxycodone works by binding to receptors in the brain and spine that control pain.
Some of the major players in the oxycodone market are Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt, Mylan, Sun Pharmaceutical (Chattem Chemicals), Impax Laboratories, Indivior.
The oxycodone market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxycodone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxycodone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxycodone Market - Supply Chain
4.5. Global Oxycodone Market Forecast
4.5.1. Oxycodone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxycodone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxycodone Market Absolute $ Opportunity
5. Global Oxycodone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxycodone Market Size and Volume Forecast by Type
5.3.1. Long Acting Oxycodone
5.3.2. Short Acting Oxycodone
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxycodone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxycodone Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxycodone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxycodone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxycodone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxycodone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxycodone Demand Share Forecast, 2019-2026
9. North America Oxycodone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxycodone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxycodone Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxycodone Market Size and Volume Forecast by Type
9.7.1. Long Acting Oxycodone
9.7.2. Short Acting Oxycodone
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxycodone Demand Share Forecast, 2019-2026
10. Latin America Oxycodone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxycodone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxycodone Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxycodone Market Size and Volume Forecast by Type
10.7.1. Long Acting Oxycodone
10.7.2. Short Acting Oxycodone
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxycodone Demand Share Forecast, 2019-2026
11. Europe Oxycodone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxycodone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxycodone Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxycodone Market Size and Volume Forecast by Type
11.7.1. Long Acting Oxycodone
11.7.2. Short Acting Oxycodone
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxycodone Demand Share, 2019-2026
12. Asia Pacific Oxycodone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxycodone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxycodone Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxycodone Market Size and Volume Forecast by Type
12.7.1. Long Acting Oxycodone
12.7.2. Short Acting Oxycodone
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxycodone Demand Share, 2019-2026
13. Middle East & Africa Oxycodone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxycodone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxycodone Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxycodone Market Size and Volume Forecast by Type
13.7.1. Long Acting Oxycodone
13.7.2. Short Acting Oxycodone
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxycodone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxycodone Market: Market Share Analysis
14.2. Oxycodone Distributors and Customers
14.3. Oxycodone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Purdue Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mallinckrodt
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mylan
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sun Pharmaceutical (Chattem Chemicals)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Impax Laboratories
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Indivior
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
